Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR Trial in Pulmonary Sarcoidosis
NCT02024555Phase 2Completed
- Sponsor
- Vanderbilt University
- Start
- Mar 2014
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levofloxacin, ethambutol, azithromycin, rifampicin in pulmonary sarcoidosis, sponsored by Vanderbilt University. Started Mar 2014; status: completed.
02
Drugs
levofloxacinethambutolazithromycinrifampicin
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NCT02024555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02024555.